4.7 Letter

Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients

Journal

KIDNEY INTERNATIONAL
Volume 101, Issue 6, Pages 1282-1286

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2022.04.009

Keywords

COVID-19; kidney transplant; SARS-CoV-2; vaccine

Funding

  1. CareDx, Inc (Brisbane, CA) [2021A008053]
  2. Harold and Ellen Danser Endowed/Distinguished Chair in Transplantation at Massachusetts General Hospital (Boston, MA)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available